Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 5/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8222305 | 0.91 | OPRM1 (0.41) | DNM1TSHROPRM1FDPSPTPN1 | |
| SCHEMBL8221097 | 0.91 | OPRM1 (0.41) | DNM1TSHROPRM1FDPSPTPN1 | |
| SCHEMBL17103146 | 0.84 | TSHR (0.32) | TSHR | |
| SCHEMBL15929840 | 0.83 | CA2 (0.38) | ALDH1A1TDP1DNM1CYP3A4TSHR | |
| SCHEMBL10781652 | 0.81 | DNM1 (0.42) | DNM1TSHRCA2OPRM1PTPN1 | |
| SCHEMBL27256773 | 0.80 | ALDH1A1 (0.36) | ALDH1A1TDP1DNM1CYP3A4TSHR | |
| SCHEMBL27805487 | 0.79 | OPRM1 (0.39) | DNM1CA1OPRM1FDPSPTPN1 | |
| SCHEMBL3721678 | 0.79 | DNM1 (0.38) | ALDH1A1TDP1DNM1CYP3A4TSHR | |
| SCHEMBL4665656 | 0.78 | OPRM1 (0.42) | DNM1TSHROPRM1FDPSPTPN1 | |
| SCHEMBL3034928 | 0.76 | CA2 (0.33) | ALDH1A1TDP1CYP3A4TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11186531-B2 | Production method for alkene | KUREHA CORPORATION (JP) | 2021-11-30 | — | — | US | disclosed |
| US-20210047252-A1 | PRODUCTION METHOD FOR ALKENE | KUREHA CORPORATION (JP) | 2021-02-18 | — | — | US | disclosed |
| EP-0284005-B1 | METHOD OF PRODUCTION OF POLYOLEFINS | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1991-12-18 | — | — | EP | disclosed |
| US-4981930-A | POLYMERIZATION CATALYSTS | IDEMITSU PETROCHEMICAL COMPANY LIMITED (JP) | 1991-01-01 | — | — | US | disclosed |
| EP-0284005-A2 | Method of production of polyolefins | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1988-09-28 | — | — | EP | disclosed |
| US-4748283-A | POLYMERIZATION CATALYSTS | LITHIUM CORPORATION OF AMERICA (US) | 1988-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047252-A1 | PRODUCTION METHOD FOR ALKENE | ALK, ALKBH3, ALKBH1 | ALDH1A1 299/4885TDP1 515/4885DNM1 3753/4885 |
| US-11186531-B2 | Production method for alkene | ALK, ALKBH3, ALKBH1 | ALDH1A1 299/4885TDP1 515/4885DNM1 3753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.